segment of the population is resistant to adopting new behaviors, as described in the diffusion of innovation theory. 3 Although this portion of the population is not included in studies on commitment devices, a negative response to any intervention might be expected. Initial predisposition to change will affect the perception of the intervention and its effectiveness on behavior change.
Second, as commitment devices are implemented in the general population, it is important to carefully consider how these interventions are perceived based on research on framing and behavior change. A commitment device can be perceived positively as a motivator, reinforcing new behaviors (carrot). But the same commitment device can be perceived as a requirement, which unless fulfilled, will lead to the loss of a previously acquired privilege (stick).
Tversky and Kahneman 4 showed that response to change is more intense when the changes are unfavorable (result in losses) than when they result in improvements. Yet the feeling of constraint can decrease a person's willingness to adopt a new behavior and can shift motivation from intrinsic to extrinsic. 5 Because long-term change is more effective with intrinsic motivation, this form of nudging for the general population may actually have an unintended negative effect.
As public health policies seek to nudge the population to healthier behaviors, the implementation of commitment devices or other default changes should include careful consideration of patient perceptions.
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1.
Taking disulfiram in the morning so a person with alcoholism will be sick if he or she drinks alcohol in the evening is an example of a commitment device. Scheduling workouts with a partner to increase the cost of skipping the gym (ie, disappointing friends) is another example of a commitment device. Recent behavioral science research finds significant demand for commitment devices and that such devices can improve health outcomes ranging from weight loss to smoking cessation.
An obvious question is why would anyone voluntarily impose restrictions on himself or herself. The answer is that some people are self-aware about the fact that owing to limited willpower, they sometimes do not follow through on their best intentions and thus could fail to accomplish their current health goals. These people find commitment devices attractive as a means of precommitting themselves to pursuing healthy future behaviors.
Dr Blondon raises the possibility that encouraging increased use of commitment devices may have some unintended negative consequences. The hypotheses she puts forth can only be tested with data, and we agree that future research is needed. In fact, our Viewpoint called for additional research addressing such important open questions. That said, we respectfully contest Blondon's predictions about what such research would uncover.
Blondon's first proposition is that individuals who would not readily adopt commitment devices without encouragement may react unfavorably if they are urged to adopt them. We would predict just the opposite. Persons who most readily adopt commitment devices are unusually self-aware about the risk that they may not achieve their health goals due to future willpower failures.
1 Such self-aware patients are the most likely to seek out and use other support systems and therefore may be likely to benefit the least from commitment devices. The second concern Blondon raises is that experiencing the restrictions associated with commitment devices could suppress intrinsic motivation and therefore suppress future demand for commitment devices. A recent study found that the majority (57%) of people who experienced an externally imposed restriction designed to induce more exercise subsequently elected to self-impose the same restriction (ie, use it as a commitment device) to motivate more exercise moving forward.
2 Thus, the only evidence we know of to date addressing this issue suggests commitment devices do not appear to undermine future motivation. Even though more research is needed on how best to encourage the use of commitment devices and who will benefit most from them, we believe that they can and should be used to improve societal health outcomes. 
Editor's Note

Clarification of Inaccurate Statement
The editors would like to clarify the last sentence of the first paragraph of the Brief Report entitled "Medical Communication Companies and Industry Grants" published in the December 18, 2013, issue of JAMA, as we believe the sentence could be read as suggesting that all medical communication companies participate in certain marketing activities, which is not accurate. The authors disagree with this interpretation and the need for a clarification. The sentence has been modified online to read: "Known best for arranging continuing medical education (CME) programs, they also may develop prelaunch and branding campaigns and produce digital and print publications." 2554-2558. doi:10.1001/jama.2013.281638), the last sentence of the first paragraph in the article requires clarification. It should read: "Known best for arranging continuing medical education (CME) programs, they also may develop prelaunch and branding campaigns and produce digital and print publications." This article was corrected online.
Errors in Clinical Crossroads:
In the Clinical Crossroads article entitled "Assessment and Lifestyle Management of Patients With Obesity: Clinical Recommendations From Systematic Reviews," published in the September 3, 2014 , issue of JAMA (2014 312[9]:943-952. doi:10.1001 /jama.2014 , several errors occurred. On page 944, in the third paragraph of the left column, the second sentence should have read "Her only medication is paroxetine, 50 mg/d." On page 945, the secondto-last sentence of the second paragraph under "Taking an Obesity-Focused History" also should have stated that Ms T is taking paroxetine, not fluoxetine. On page 950, in the paragraph under "Recommendations for Ms T," the third sentence should have stated that Ms T should try to accumulate at least 150 minutes of moderately vigorous physical activity on a weekly basis [not a daily basis] and discuss with her physician the substitution of paroxetine [not fluoxetine] with an alternative antidepressant. This article was corrected online.
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